Sign In
Buy CRSP
$52.08
+0.0600 (+0.115%)
At Close: Jun 03, 2026
Why CRISPR Therapeutics Stock Is Tumbling Today
09:01am, Wednesday, 13'th Oct 2021
CRISPR Therapeutics AG (NASDAQ: CRSP) is trading lower Wednesday after the company reported results from its Phase 1 CARBON trial of CTX110 in relapsed or refractory CD19+ B-cell malignancies. “We
Will CRISPR Stock Rebound After A 17% Fall In A Month?
09:00am, Wednesday, 13'th Oct 2021
The stock price of CRISPR Therapeutics, a biotechnology gene editing company focused on developing gene-based medicines for human diseases, reached an all-time high of $210 in January of this year bef
Crispr's stock is down 5% after sharing early-stage data for its CAR-T therapy candidate
07:54am, Wednesday, 13'th Oct 2021
Shares of Crispr Therapeutics Inc. CRSP, +1.93% were down 5.8% in premarket trading on Wednesday, the day after the company announced data from a Phase 1 clinical trial for its CAR-T cell therapy cand
CRSP Stock: Why It Fell Today
07:27am, Wednesday, 13'th Oct 2021
The stock price of Crispr Therapeutics AG (NASDAQ: CRSP) fell by over 6% today. This is why it happened.
How to Invest in Biotech Stocks in a Bear Market
06:25am, Wednesday, 13'th Oct 2021
Hint: it doesn't really matter what kind of market it is.
-58% overall response rate (ORR) and 38% complete response (CR) rate in large B-cell lymphoma (LBCL) with a single dose of CTX110 at Dose Level 2 (DL2) and above on an intent-to-treat (ITT) basis-
Cathie Wood's ARK Invest Buys Over 400,000 Shares of CRISPR
08:05am, Monday, 11'th Oct 2021
A couple of ARK Invest funds run by ETF star Cathie Wood made a huge buy on Friday.
Why CRISPR Therapeutics (CRSP) Stock is Falling Today
07:05pm, Friday, 08'th Oct 2021
Shares of leading gene editing company CRISPR Therapeutics (CRSP) are sliding on Friday. What's behind the slump?
Why CRISPR Therapeutics Stock Fell 10.4% Last Month
09:10am, Thursday, 07'th Oct 2021
CRISPR Therapeutics stock is now down roughly 33% across 2021's trading.
CRISPR Therapeutics to Host Virtual Event Highlighting CTX110™ Clinical Data
04:05pm, Tuesday, 05'th Oct 2021
-Management to host conference call and webcast on October 12th at 4:30 p.m. ET-
CRISPR Therapeutics AG (CRSP) CEO Samarth Kulkarni Presents at Chardan's 5th Annual Genetic Medicines Conference Call Transcript
04:15pm, Monday, 04'th Oct 2021
CRISPR Therapeutics AG (CRSP) CEO Samarth Kulkarni Presents at Chardan's 5th Annual Genetic Medicines Conference Call Transcript
CRISPR Therapeutics AG (CRSP) Gains As Market Dips: What You Should Know
07:30pm, Thursday, 30'th Sep 2021
In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $111.93, marking a +1.57% move from the previous day.
3 Biotech Stocks Wall Street Thinks Could Rise 44% or Better
06:17am, Thursday, 30'th Sep 2021
A stock market that soured on biotech stocks in general is presenting some bargain opportunities.
Here's Why Editas Stock Dropped After Data From CRISPR-Based Retinal Disorder Candidate
12:25pm, Wednesday, 29'th Sep 2021
Editas Medicine Inc (NASDAQ: EDIT) has announced initial clinical data from the ongoing Phase 1/2 BRILLIANCE trial of EDIT-101 for blindness due to Leber congenital amaurosis 10 (LCA10), a CEP290-
Reasons To Buy Vertex Below $200
07:00am, Wednesday, 29'th Sep 2021
Reasons To Buy Vertex Below $200
